Monogram Orthopaedics (MGRM) Expected to Announce Quarterly Earnings on Wednesday

Key Points

• Monogram Orthopaedics is expected to announce its Q2 2025 earnings on August 13th, with analysts forecasting a loss of ($0.11) per share.
• The company's stock price is currently down 0.7%, opening at $5.43, and it has experienced a twelve-month price range between $1.92 and $6.02.
• Institutional investor Jane Street Group LLC raised its stake in Monogram Orthopaedics by 83%, indicating growing interest in the company.

Monogram Orthopaedics (NASDAQ:MGRM - Get Free Report) will likely be releasing its Q2 2025 earnings data before the market opens on Wednesday, August 13th. Analysts expect the company to announce earnings of ($0.11) per share for the quarter.

Monogram Orthopaedics (NASDAQ:MGRM - Get Free Report) last issued its earnings results on Wednesday, May 14th. The company reported ($0.10) EPS for the quarter, beating the consensus estimate of ($0.12) by $0.02. On average, analysts expect Monogram Orthopaedics to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Monogram Orthopaedics Stock Up 1.3%

Shares of NASDAQ:MGRM traded up $0.07 during mid-day trading on Wednesday, reaching $5.50. 106,338 shares of the stock were exchanged, compared to its average volume of 966,552. The stock's 50 day simple moving average is $3.78 and its 200-day simple moving average is $3.06. Monogram Orthopaedics has a one year low of $1.92 and a one year high of $6.02. The company has a market cap of $196.30 million, a P/E ratio of -12.22 and a beta of 0.69.

Institutional Investors Weigh In On Monogram Orthopaedics

A hedge fund recently raised its stake in Monogram Orthopaedics stock. Jane Street Group LLC grew its stake in shares of Monogram Orthopaedics Inc. (NASDAQ:MGRM - Free Report) by 83.0% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,426 shares of the company's stock after purchasing an additional 8,810 shares during the quarter. Jane Street Group LLC owned about 0.06% of Monogram Orthopaedics worth $57,000 at the end of the most recent quarter. Institutional investors own 0.45% of the company's stock.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.